The global market for dental gypsum is anticipated to grow at a CAGR of 5% during the forecast period of 2024 to 2032. This is attributable to the rise in dental tourism, demand for cosmetic dentistry, and oral health awareness. The adoption of digital dentistry technologies, such as CAD/CAM systems and 3D printing, is anticipated to contribute to industry growth.
The acute respiratory distress syndrome (ARDS) devices market is expected to grow at a CAGR of 7.5% during the forecast period of 2024 to 2032. Acute respiratory distress syndrome (ARDS) is a severe lung condition that can be caused by a variety of underlying conditions, including sepsis, pneumonia, and trauma. It is marked by inflammation and fluid accumulation in the lungs, which can lead to breathing difficulties and low blood oxygen levels.
The market for Acute Lung Injury is expected to rise at a CAGR of 3.5% during the forecast period of 2024 to 2032. Acute Lung Injury (ALI) is a severe medical condition in which lung tissues become inflamed and damaged, causing difficulty breathing and low blood oxygen levels. Infections, chemical exposure, and trauma are significant risk factors for ALI.
Despite advances in treatment, the high morbidity and death rate of heart failure is driving the global absorbable antibacterial envelope market. Mortality in individuals with heart failure is not only caused by hemodynamic failure; ventricular arrhythmias might also be to blame. In the coming years, the use of implantable cardioverter defibrillators (ICDs) to reduce arrhythmic sudden fatalities is anticipated to boost the market. Moreover, cardiac resynchronization therapy (CRT) is another promising treatment option for heart failure patients.
Acquired von Willebrand syndrome is a highly heterogeneous bleeding disorder, usually displays mild to moderate hemorrhagic symptoms that may at times be severe too. Many a time the severity increases post-surgery. AvWD is considered as a rare disorder, however, the actual prevalence is not as rare.
Adhesive bandages market accounted for a market value of US$ 1,895.0 Mn in 2017 and projected to grow at a CAGR of 4.8% during the forecast period from 2018 to 2026. The key factors responsible for growth of adhesive bandages globally is the rising awareness related to the acute wound protection in developing countries, and increasing awareness programmes for diabetes patients to treat acute wound efficiently with adhesive bandages.
Acute care needleless connectors market accounted for a market value of US$ 648.8 Mn in 2017 and projected to grow at a CAGR of 5.1% during the forecast period from 2018 to 2026. The key factors responsible for growth of acute care needleless connectors market are the rising prevalence of needlestick injuries, high awareness related to the advantages of acute care needleless connectors in healthcare personnel, and increasing number of ambulatory centres. According to the World Health Organization (WHO) 1 in 10 healthcare personnel globally sustain a needlestick injury every year.
The equine healthcare market is expected to grow at a CAGR of 6.1% during the forecast period of 2024 to 2032, driven by key drivers such as preventive healthcare measures, advancements in diagnostics and treatment, and the rising focus on equine sports and recreation. However, challenges related to cost and accessibility pose constraints. Market segmentation underscores the dominance of specific product categories and indications, while geographic trends highlight regional variations in market dynamics.
The global botulinum toxin market is growing significantly, and is expected to grow at 7.2% by 2032. Worldwide growing cosmetic & surgical procedures, treatment with botulinum toxin A (BNT-A) for various therapeutic procedures along with growing population aged between 25 to 60 years and growing demand for minimally invasive procedures are the major factors driving the overall growth of the global botulinum toxin market.
Inferior vena cava (IVC) is the largest vein in the human body that carries deoxygenated blood from inferior part of the body to the heart. An inferior vena cava filter is implanted in the inferior vena cava to capture embolism, blood clot, preventing them from reaching the lungs. Implantation of these devices is either permanent or temporary depending upon the need of therapy. The prominent factors that fuel the growth of the global inferior vena cava (IVC) filters market include rise in preference for minimally invasive surgeries with improved medical imaging across various medical settings.
The therapeutic Area Market refers to a certain area of diseases or ailments for which there are established medical treatments or prospective remedies in development. It is a method of classifying pharmaceuticals without regard to the type of therapy, mode of action, or manufacturer, but rather by the ailment it treats. Oncology expenditures are predicted to exceed US $300 billion by 2025. With estimated expenditures of roughly US $190 billion, immunology is expected to rank second.
According to the January 2021 publication "The Longitudinal Ageing Study in India (LASI)," around 75 million Indians aged 60 and older suffer from a chronic condition. Around 45 million suffer from cardiovascular disease and hypertension, while 20 million have diabetes. Consequently, the high prevalence of chronic diseases in the country will increase the demand for cost-effective therapies, such as digital therapeutic devices, and drive the market under study. There has been an increase in the therapeutic use of technology for medical ailments. People in developed markets are becoming increasingly aware of the advanced medical treatments available. The Organization for Economic Co-operation and Development said in July 2019 that healthcare spending as a percentage of GDP climbed significantly in 2020, as the economic situation deteriorated and health spending soared in several OECD nations. In 2020, health expenditures per capita for a group of 16 nations are projected to increase by approximately 4.9% on average. So, the choice has turned toward enhanced services in the medical industry, including the rising demand for therapeutic gadget developments. Product approval is another aspect contributing to the expansion of the industry. In December 2020, for instance, the United States Food and Drug Administration granted San Francisco and London-based Mahana Therapeutics a De Novo marketing authorization for a product called Parallel, which according to company literature is an 8-week cognitive behavioral therapy program for people with irritable bowel syndrome. Such approvals will stimulate market expansion.
The increasing prevalence of chronic illnesses contributes to the segment's expansion. According to the International Diabetes Federation (IDF), roughly 536 million adults (20-79 years of age) had diabetes in 2021, and this number will increase to 783 million by 2045. In the majority of countries, the prevalence of type 2 diabetes is increasing, and 79% of adults with diabetes reside in low- and middle-income countries, where 1 in 5 persons over 65 have the disease. In the majority of countries, the prevalence of type 2 diabetes is increasing, and 79% of adults with diabetes reside in low- and middle-income countries, where 1 in 5 persons over 65 have the disease.
Acute Market Reports specializes in market research and consulting for therapeutic area markets. Our clients benefit from Acute Market Reports' futuristic research technique, which enables them to make timely, well-considered business decisions. We work with a wide range of industry participants to give cutting-edge strategic research solutions to our global clients.
